首页> 美国卫生研究院文献>other >Use and Impact of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors

【2h】

Use and Impact of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors

机译：蛋白酶体抑制剂治疗骨髓瘤患者的带状疱疹预防用途和影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 other
作者
Siyang Leng; Suzanne Lentzsch; Yanhan Shen; Wei-Yann Tsai; Jason D. Wright; Dawn L. Hershman; Alfred I. Neugut;
展开▼
作者单位

展开▼
年(卷),期 -1(59),10
年度 -1
页码 2465–2469
总页数 12
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Use and impact of herpes zoster prophylaxis in myeloma patients treated with proteasome inhibitors [J] . Leng Siyang, Lentzsch Suzanne, Shen Yanhan, Leukemia and lymphoma . 2018,第9a10期

机译：带有蛋白酶体抑制剂治疗的骨髓瘤患者的疱疹预防疱疹预防的使用和影响
2. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients [J] . K?nigC., KleberM., ReinhardtH., Annals of hematology . 2014,第3期

机译：在来那度胺治疗的多发性骨髓瘤患者中水痘带状疱疹病毒感染（包括复杂的水痘带状疱疹病毒和单纯疱疹病毒感染）的发生率，危险因素和实施的预防措施
3. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients [J] . K?nigC., KleberM., ReinhardtH., Annals of hematology . 2014,第3期

机译：在Lenalidomide治疗的多发性骨髓瘤患者中，发生异常疱疹病毒感染的发病率，危险因素和实施的Pryicella带状疱疹病毒感染和单纯疱疹病毒感染。
4. Analysis of The Rule of Traditional Chinese Medicine for Treating Herpes Zoster [C] . Yanyi Wu, Mingsan Miao International Conference on Advanced Composite Materials and Manufacturing Engineering . 2020

机译：疱疹治疗中药统治分析
5. The Role of Klf9 in Cell Stress-Induced Cell Death In Normal Cells and in the Therapeutic Response of Multiple Myeloma Cells to Proteasome Inhibitors [D] . Fink, Emily 2017

机译：Klf9在正常细胞中细胞应激诱导的细胞死亡中的作用以及在多发性骨髓瘤细胞对蛋白酶体抑制剂的治疗反应中的作用
6. The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors [O] . Barry Paul, Yue Zhao, Gavin Loitsch, 2020

机译：用免疫调节剂和/或蛋白酶体抑制剂处理新诊断多发性骨髓瘤患者临床结果的影响
7. Use and impact of herpes zoster prophylaxis in myeloma patients treated with proteasome inhibitors [O] . Siyang Leng, Suzanne Lentzsch, Yanhan Shen, 2018

机译：带有蛋白酶体抑制剂治疗的骨髓瘤患者中疱疹预防疱疹预防的使用和影响

Use and Impact of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅